Cargando…

Multiplex meta-analysis of RNA expression to identify genes with variants associated with immune dysfunction

OBJECTIVE: We demonstrate a genome-wide method for the integration of many studies of gene expression of phenotypically similar disease processes, a method of multiplex meta-analysis. We use immune dysfunction as an example disease process. DESIGN: We use a heterogeneous collection of datasets acros...

Descripción completa

Detalles Bibliográficos
Autores principales: Morgan, Alexander A, Pyrgos, Vasilios J, Nadeau, Kari C, Williamson, Peter R, Butte, Atul Janardhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277634/
https://www.ncbi.nlm.nih.gov/pubmed/22319178
http://dx.doi.org/10.1136/amiajnl-2011-000657
Descripción
Sumario:OBJECTIVE: We demonstrate a genome-wide method for the integration of many studies of gene expression of phenotypically similar disease processes, a method of multiplex meta-analysis. We use immune dysfunction as an example disease process. DESIGN: We use a heterogeneous collection of datasets across human and mice samples from a range of tissues and different forms of immunodeficiency. We developed a method integrating Tibshirani's modified t-test (SAM) is used to interrogate differential expression within a study and Fisher's method for omnibus meta-analysis to identify differentially expressed genes across studies. The ability of this overall gene expression profile to prioritize disease associated genes is evaluated by comparing against the results of a recent genome wide association study for common variable immunodeficiency (CVID). RESULTS: Our approach is able to prioritize genes associated with immunodeficiency in general (area under the ROC curve = 0.713) and CVID in particular (area under the ROC curve = 0.643). CONCLUSIONS: This approach may be used to investigate a larger range of failures of the immune system. Our method may be extended to other disease processes, using RNA levels to prioritize genes likely to contain disease associated DNA variants.